TJ Lehky, FM Iwamoto, TN Kreisl, MK Floeter… - Neurology, 2011 - AAN Enterprises Results: Six patients were observed to develop a reversible weakness that correlated with the administration of the tandutinib. The onset of weakness after starting tandutinib occurred within 3 to 112 days and in less than 15 days in 3 patients. Electrophysiologic studies showed ... Cited by 3 - Related articles - All 3 versions
D Selcen, VC Juel, LD Hobson-Webb, EC Smith… - Neurology, 2011 - AAN Enterprises ... Association of EBS with amyasthenic syndrome (MyS) was documented in a single patient in 1999. ... 20 Some patients with EBS and MD (EBS-MD) also had symptoms suggesting amyasthenic disorder 9,21,–,23 but this was not suspected or confirmed by specific studies. ... Related articles - All 3 versions
E Auriel, K Regev, A Dori… - Muscle & Nerve, 2011 - Wiley Online Library ... and the H1N1 virus. We examined these vaccination practices in a population of MG patients and sought a temporal association between the administration of one or both vaccines and amyasthenic exacerbation. METHODS. ... Related articles - All 2 versions
E Ruffini, PL Filosso, C Mossetti, MC Bruna… - European Journal of …, 2011 - EACTS ... When considering WHO histology as the outcome variable, we found that, on moving from A to B3 types, a higher Masaoka stage (OR 0.46, 95% CI 0.36–0.60) and a myasthenic status (OR 0.39, 95% CI 0.24–0.63) are more likely. ... Cited by 1 - Related articles - All 5 versions
RA Gross - Neurology, 2011 - AAN Enterprises ... See p. 219; Editorial, p. 208 Neuromuscular junction toxicity with tandutinib induces amyasthenic-like syndrome Six patients with glioblastome multiforme and being treated with a drug regimen containing tandutinib developed ... All 2 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
